Edwards Lifesciences to spin off critical-care unit, sets $1B stock buyback
December 07, 2023 at 12:06 PM EST
Katie Szyman will be chief executive of the independent company, which is expected to generate $905 million in sales in 2023.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|